Sutro Biopharma, Inc. (NASDAQ:STRO)

About the company

Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. It focuses on next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

168

CEO

William J. Newell

Exchange

NASDAQ

Website

http://www.sutrobio.com

$41.00M

Total Revenue

168

Employees

$194.58M

Market Capitalization

-3.19

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-60M

Net Margin (in %)

Total net margin

$-61M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 391056.16 82729.00 6.28 22.79 20.75
Pfizer Inc. PFE 198619.60 50660.00 3.01 12.57 31.17
Merck & Co., Inc. MRK 198480.10 48081.00 7.45 19.58 21.10
Eli Lilly & Co. LLY 148789.44 23087.00 50.49 26.23 23.97
AbbVie, Inc. ABBV 145224.24 34057.00 -23.24 17.32 24.65
Bristol Myers Squibb Co. BMY 107455.19 31006.00 2.61 91.36 3.08
Repligen Corp. RGEN 6248.01 286.00 5.99 272.24 8.11
Reata Pharmaceuticals, Inc. RETA 4580.56 20.00 21.70 -14.73 -150.30
Nektar Therapeutics NKTR 4111.36 137.00 3.21 -8.95 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3625.44 1.00 33.52 -5.55 None
Allakos, Inc. ALLK 3177.20 None 6.90 -33.97 None
OPKO Health, Inc. OPK 2356.83 891.00 1.68 -8.06 -32.92
Karuna Therapeutics, Inc. KRTX 2343.38 None 6.12 -57.78 None
ADC Therapeutics SA ADCT 2338.74 2.00 27.59 -20.05 None
Turning Point Therapeutics, Inc. TPTX 2157.84 None 6.49 -18.05 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
IGM Biosciences, Inc. IGMS 2038.87 None 8.98 -37.58 None
Apellis Pharmaceuticals, Inc. APLS 2020.26 None 8.92 -4.84 None
Principia Biopharma, Inc. PRNB 1752.24 30.00 6.24 -24.93 -242.01
Springworks Therapeutics, Inc. SWTX 1554.02 None 5.05 -24.92 None
Y-mAbs Therapeutics, Inc. YMAB 1436.71 None 8.80 -15.59 None
Zymeworks, Inc. ZYME 1301.06 26.00 2.70 -7.67 -629.37
Tricida, Inc. TCDA 1263.22 None 6.49 -5.98 None
Akcea Therapeutics, Inc. AKCA 1232.87 341.00 2.53 -43.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1169.85 None 6.06 -9.67 None
Odonate Therapeutics, Inc. ODT 1084.89 None 8.89 -9.64 None
Phibro Animal Health Corp. PAHC 1039.35 818.00 5.25 28.17 4.49
Arcutis Biotherapeutics, Inc. ARQT 1020.09 None 4.35 -16.31 None
Akero Therapeutics, Inc. AKRO 986.58 None 9.98 -19.44 None
Athenex, Inc. ATNX 943.02 123.00 5.78 -8.76 -87.86
Constellation Pharmaceuticals, Inc. CNST 906.88 None 4.27 -9.77 None
Gossamer Bio, Inc. GOSS 774.70 None 3.14 -3.90 None
G1 Therapeutics, Inc. GTHX 763.80 1.00 3.31 -5.83 None
Phathom Pharmaceuticals, Inc. PHAT 735.75 None 4.08 -2.70 None
Quanterix Corp. QTRX 726.84 60.00 6.41 -16.62 -71.52
Oric Pharmaceuticals, Inc. ORIC 680.40 None -7.39 -22.50 None
Amneal Pharmaceuticals, Inc. AMRX 672.67 1679.00 4.63 -3.09 -11.85
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 655.98 19.00 60.80 -23.58 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Krystal Biotech, Inc. KRYS 641.92 None 3.74 -30.95 None
Applied Therapeutics, Inc. APLT 617.54 14.00 3.99 -12.53 -19.41
Aprea Therapeutics, Inc. APRE 569.31 None 5.04 -16.84 None
Keros Therapeutics, Inc. KROS 563.22 8.00 -25.44 -26.52 -285.35
Oyster Point Pharma, Inc. OYST 513.24 None 5.16 -8.92 None
Mirum Pharmaceuticals, Inc. MIRM 465.50 None 3.03 -6.87 None
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 444.50 None 5.48 -6.89 None
Biospecifics Technologies Corp. BSTC 441.21 40.00 3.58 18.87 61.80
Fulcrum Therapeutics, Inc. FULC 423.89 1.00 7.14 -6.14 None
Satsuma Pharmaceuticals, Inc. STSA 417.01 None 4.10 -11.46 None
Osmotica Pharmaceuticals Plc OSMT 416.88 232.00 3.16 -1.52 -115.44
DURECT Corp. DRRX 383.16 28.00 29.43 -15.85 -82.94
Imara, Inc. IMRA 375.70 None 3.63 -10.68 None
Relmada Therapeutics, Inc. RLMD 363.42 0.00 5.42 -30.36 -877.66
Kala Pharmaceuticals, Inc. KALA 360.90 6.00 3.95 -3.93 None
TCR2 Therapeutics, Inc. TCRR 359.28 None 2.46 -35.64 None
Ocular Therapeutix, Inc. OCUL 353.04 6.00 -43.26 -3.85 None
Crinetics Pharmaceuticals, Inc. CRNX 350.16 1.00 4.42 -6.00 -447.78
Ovid Therapeutics, Inc. OVID 315.00 None 7.45 -4.83 None
IDEAYA Biosciences, Inc. IDYA 283.40 None 4.31 -6.50 None
Aeglea Biotherapeutics, Inc. AGLE 276.54 4.00 8.73 -3.45 -523.27
Urovant Sciences Ltd. UROV 276.00 None -4.89 -1.91 None
HOOKIPA Pharma, Inc. HOOK 250.12 13.00 2.26 -5.53 -333.02
AMAG Pharmaceuticals, Inc. AMAG 246.16 321.00 0.94 -0.66 -115.05
Spero Therapeutics, Inc. SPRO 242.63 12.00 3.19 -2.98 -656.72
Verrica Pharmaceuticals, Inc. VRCA 220.00 None 4.02 -7.21 None
KalVista Pharmaceuticals, Inc. KALV 207.00 13.00 2.45 -7.01 -229.44
Sutro Biopharma, Inc. STRO 194.58 41.00 3.69 -3.19 -148.06
Lannett Co., Inc. LCI 190.76 542.00 0.65 -6.27 -5.77
Veru, Inc. VERU 189.15 39.00 6.47 -19.40 -25.53
Kaleido Biosciences, Inc. KLDO 184.50 None 6.54 -2.52 None
Galera Therapeutics, Inc. GRTX 183.75 None 3.43 -2.79 None
LogicBio Therapeutics, Inc. LOGC 171.35 1.00 5.17 -4.03 None
Protara Therapeutics, Inc. TARA 153.54 None 2.31 -9.96 None
Liquidia Technologies, Inc. LQDA 152.57 8.00 11.96 -3.10 -602.17
Avenue Therapeutics, Inc. ATXI 149.92 532.00 27.56 -10.30 26.69
Gritstone Oncology, Inc. GRTS 144.72 4.00 1.30 -1.39 None
scPharmaceuticals, Inc. SCPH 139.08 119.00 3.55 -4.44 -27.05
Lyra Therapeutics, Inc. LYRA 138.12 1.00 -1.17 -8.28 -491.16
Tyme Technologies, Inc. TYME 136.85 None 7.93 -6.26 None
Evelo Biosciences, Inc. EVLO 132.80 None 4.88 -1.51 None
Ayala Pharmaceuticals, Inc. AYLA 132.48 3.00 -3.12 -6.42 -679.19
Harrow Health, Inc. HROW 127.66 51.00 8.18 -5.17 -47.54
TFF Pharmaceuticals, Inc. TFFP 127.11 None 4.92 -3.28 None
PhaseBio Pharmaceuticals, Inc. PHAS 127.02 2.00 2.35 -2.65 None
Cyclerion Therapeutics, Inc. CYCN 125.28 6.00 1.58 -1.21 None
Mustang Bio, Inc. MBIO 120.40 None 2.81 -2.45 None
Immunic, Inc. IMUX 118.50 None 3.49 -53.86 None
Aquestive Therapeutics, Inc. AQST 117.88 49.00 -6.79 -1.68 -139.64
NeuBase Therapeutics, Inc. NBSE 110.08 None 46.25 -2.46 None
Corvus Pharmaceuticals, Inc. CRVS 109.18 None 1.75 -2.31 None
Evolus, Inc. EOLS 91.80 45.00 1.65 -0.91 -217.51
Eton Pharmaceuticals, Inc. ETON 89.28 1.00 9.73 -4.47 None
Trevi Therapeutics, Inc. TRVI 88.56 None 1.88 -3.02 None
Milestone Pharmaceuticals, Inc. MIST 88.00 None 0.87 -1.41 None
EyePoint Pharmaceuticals, Inc. EYPT 77.97 26.00 5.50 -1.59 -196.30
Xeris Pharmaceuticals, Inc. XERS 76.72 4.00 3.81 -0.59 None
Clearside Biomedical, Inc. CLSD 71.34 6.00 9.16 -4.05 -293.61
Aridis Pharmaceuticals, Inc. ARDS 67.05 1.00 -27.59 -2.29 -851.00
Navidea Biopharmaceuticals, Inc. NAVB 64.77 1.00 -47.62 -5.86 -65.13
Checkpoint Therapeutics, Inc. CKPT 64.60 2.00 5.57 -2.78 -949.53
Baudax Bio, Inc. BXRX 61.82 None -1.68 -0.88 None
BiomX, Inc. PHGE 60.50 None 1.59 -1.41 None
Assertio Therapeutics, Inc. ASRT 58.64 192.00 1.02 -0.36 -83.99
Genprex, Inc. GNPX 55.10 None 4.68 -4.03 None
Aerpio Pharmaceuticals, Inc. ARPO 49.20 20.00 1.48 -2.61 -51.58
Menlo Therapeutics, Inc. MNLO 46.98 2.00 3.95 -0.50 -483.51
Eyenovia, Inc. EYEN 42.56 None 4.29 -2.08 None
Edesa Biotech, Inc. EDSA 42.39 0.00 6.04 -0.45 -395.23
Annovis Bio, Inc. ANVS 37.45 None 3.43 -29.72 None
Moleculin Biotech, Inc. MBRX 36.85 None 3.20 -4.00 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Adamis Pharmaceuticals Corp. ADMP 35.44 22.00 1.36 -1.20 -140.33
AgeX Therapeutics, Inc. AGE 34.83 2.00 -45.84 -2.86 -658.11
Mannatech, Inc. MTEX 33.52 156.00 1.41 7.55 3.45
Citius Pharmaceuticals, Inc. CTXR 33.21 None 2.46 -1.92 None
Acer Therapeutics, Inc. ACER 33.00 3.00 2.41 -1.26 -274.69
Allena Pharmaceuticals, Inc. ALNA 31.28 None 4.12 -0.72 None
Oncternal Therapeutics, Inc. ONCT 31.07 3.00 3.98 -1.23 -225.89
CNS Pharmaceuticals, Inc. CNSP 27.04 None 4.69 -4.97 None
Hoth Therapeutics, Inc. HOTH 25.10 None 6.97 -2.79 None
Aileron Therapeutics, Inc. ALRN 24.60 None 3.51 -0.92 None
Millendo Therapeutics, Inc. MLND 24.15 0.00 0.57 -0.52 None
Daré Bioscience, Inc. DARE 22.80 1.00 10.00 -1.36 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.40 0.00 0.85 -0.86 None
ProPhase Labs, Inc. PRPH 19.08 9.00 1.73 -6.36 -31.15
Novan, Inc. NOVN 14.48 5.00 -3.33 -0.46 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 13.20 None 3.22 -1.74 None
PDS Biotechnology Corp. PDSB 13.09 None 1.45 -0.51 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.52 None 0.64 -0.36 None
Brickell Biotech, Inc. BBI 4.50 5.00 1.48 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Brokerages Expect Sutro Biopharma Inc (NASDAQ:STRO) Will Post Earnings of -$0.59 Per Share

11d ago, source: modernreaders.com

Equities analysts predict that Sutro Biopharma Inc (NASDAQ:STRO) will report earnings of ($0.59) per share for the current quarter, according to Zacks. Four analysts have issued estimates for Sutro ...

Sutro Biopharma Inc.

5d ago, source: MarketWatch

Currently, Joseph M. Lobacki is Chief Executive Officer & Director at Artax Biopharma, Inc. Mr. Lobacki is also on the board of Sutro Biopharma, Inc. In his past career Mr. Lobacki was Chief ...

Were Hedge Funds Right About Souring On Sutro Biopharma, Inc. (STRO)?

14d ago, source: YAHOO!

In this article, we will take a closer look at hedge fund sentiment towards Sutro Biopharma, Inc. (NASDAQ:STRO) at the end of the first quarter and determine whether the smart money was really ...

BRIEF-Sutro Biopharma Presents Synergy Between Stro-002 And Immune Checkpoint At 2020 AACR Virtual Meeting

22d ago, source: Reuters

SUTRO BIOPHARMA PRESENTS NEW PRECLINICAL DATA AT 2020 AACR VIRTUAL ANNUAL MEETING II SUGGESTING SYNERGY BETWEEN ITS STRO-002 ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITORS RESULTING IN TUMOR ...

Pharma/BioPharma Q&A

27d ago, source: Labroots

Previously she served as the US Site-Head of Caprion Inc., and as Director of Analytics at Sutro Biopharma. Mimi has a B.Sc. (Honours) from St. Stephens College, New Delhi and a M.S. from University ...

Sutro Biopharma Inc STRO

7d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

BRIEF-Sutro Biopharma Presents Synergy Between Stro-002 And Immune Checkpoint At 2020 AACR Virtual Meeting

22d ago, source: Reuters

June 22 (Reuters) - Sutro Biopharma Inc: * SUTRO BIOPHARMA PRESENTS NEW PRECLINICAL DATA AT 2020 AACR VIRTUAL ANNUAL MEETING II SUGGESTING SYNERGY BETWEEN ITS STRO-002 ANTIBODY-DRUG CONJUGATE AND ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.